APOE and Alzheimer disease: Regulators of endosomal trafficking, which normally prevent BACE1 and APP from being delivered to the same compartment, have been identified as genetic risk factors for AD (APOE4, PICALM, BIN1) (Szabo et al., 2022; Maninger et al., 2024).